Craig W. Berridge - Publications

Affiliations: 
Psychology University of Wisconsin, Madison, Madison, WI 

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hupalo S, Bryce CA, Bangasser DA, Berridge CW, Valentino RJ, Floresco SB. Corticotropin-Releasing Factor (CRF) circuit modulation of cognition and motivation. Neuroscience and Biobehavioral Reviews. 103: 50-59. PMID 31212019 DOI: 10.1016/j.neubiorev.2019.06.010  0.4
2019 Spencer RC, Berridge CW. Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30683912 DOI: 10.1038/s41386-019-0314-y  0.68
2019 Hupalo S, Martin AJ, Green RK, Devilbiss DM, Berridge CW. Prefrontal Corticotropin-Releasing Factor (CRF) Neurons Act Locally to Modulate Frontostriatal Cognition and Circuit Function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30651328 DOI: 10.1523/JNEUROSCI.2701-18.2019  1
2016 Hupalo S, Berridge CW. Working Memory Impairing Actions of Corticotropin-Releasing Factor (CRF) Neurotransmission in the Prefrontal Cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27272767 DOI: 10.1038/npp.2016.85  0.4
2016 Devilbiss DM, Spencer RC, Berridge CW. Stress Degrades Prefrontal Cortex Neuronal Coding of Goal-Directed Behavior. Cerebral Cortex (New York, N.Y. : 1991). PMID 27226444 DOI: 10.1093/cercor/bhw140  1
2016 España RA, Schmeichel BE, Berridge CW. Norepinephrine at the Nexus of Arousal, Motivation and Relapse. Brain Research. PMID 26773688 DOI: 10.1016/j.brainres.2016.01.002  0.8
2015 Berridge CW, Spencer RC. Differential Cognitive Actions of Norepinephrine α2 and α1 Receptor Signaling in the Prefrontal Cortex. Brain Research. PMID 26592951 DOI: 10.1016/j.brainres.2015.11.024  1
2015 Spencer RC, Devilbiss DM, Berridge CW. The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex. Biological Psychiatry. 77: 940-50. PMID 25499957 DOI: 10.1016/j.biopsych.2014.09.013  1
2015 Arnsten AFT, Berridge CW. Catecholamine inluences on prefrontal cortex circuits and function Attention-Deficit Hyperactivity Disorder in Adults and Children. 161-173. DOI: 10.1017/CBO9781139035491.015  1
2015 Berridge CW, Arnsten AFT. Catecholamine mechanisms in the prefrontal cortex: Proven strategies for enhancing higher cognitive function Current Opinion in Behavioral Sciences. 4: 33-40. DOI: 10.1016/j.cobeha.2015.01.002  1
2014 Andrzejewski ME, Spencer RC, Harris RL, Feit EC, McKee BL, Berridge CW. The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats. Neuropharmacology. 79: 634-41. PMID 24467844 DOI: 10.1016/j.neuropharm.2014.01.018  1
2014 Schmeichel BE, Berridge CW. Amphetamine acts within the lateral hypothalamic area to elicit affectively neutral arousal and reinstate drug-seeking. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 63-75. PMID 23895988 DOI: 10.1017/S1461145713000734  1
2013 Schmeichel BE, Berridge CW. Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1078-84. PMID 23303075 DOI: 10.1038/npp.2013.6  1
2013 Schmeichel BE, Berridge CW. Wake-promoting actions of noradrenergic α1 - and β-receptors within the lateral hypothalamic area. The European Journal of Neuroscience. 37: 891-900. PMID 23252935 DOI: 10.1111/ejn.12084  1
2013 Berridge CW, Arnsten AF. Psychostimulants and motivated behavior: arousal and cognition. Neuroscience and Biobehavioral Reviews. 37: 1976-84. PMID 23164814 DOI: 10.1016/j.neubiorev.2012.11.005  1
2013 Schmeichel BE, Zemlan FP, Berridge CW. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder. Neuropharmacology. 64: 321-8. PMID 22796428 DOI: 10.1016/j.neuropharm.2012.07.005  1
2013 Berridge CW, Devilbiss DM, Spencer RC, Schmeichel BE. Neural Mechanisms Underlying the Cognition-Enhancing Actions of Pyschostimulants: Relevance to ADHD Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 168-169. DOI: 10.1016/B978-0-12-800044-1.00148-3  1
2012 Devilbiss DM, Jenison RL, Berridge CW. Stress-induced impairment of a working memory task: role of spiking rate and spiking history predicted discharge. Plos Computational Biology. 8: e1002681. PMID 23028279 DOI: 10.1371/journal.pcbi.1002681  1
2012 Devilbiss DM, Waterhouse BD, Berridge CW, Valentino R. Corticotropin-releasing factor acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2020-30. PMID 22510725 DOI: 10.1038/npp.2012.50  1
2012 Berridge CW, Schmeichel BE, España RA. Noradrenergic modulation of wakefulness/arousal. Sleep Medicine Reviews. 16: 187-97. PMID 22296742 DOI: 10.1016/j.smrv.2011.12.003  1
2012 Spencer RC, Klein RM, Berridge CW. Psychostimulants act within the prefrontal cortex to improve cognitive function. Biological Psychiatry. 72: 221-7. PMID 22209638 DOI: 10.1016/j.biopsych.2011.12.002  1
2012 Berridge CW, Shumsky JS, Andrzejewski ME, McGaughy JA, Spencer RC, Devilbiss DM, Waterhouse BD. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors. Biological Psychiatry. 71: 467-73. PMID 21890109 DOI: 10.1016/j.biopsych.2011.07.022  1
2012 Berridge CW, Devilbiss DM, Spencer RC, Schmeichel BE, Arnsten AFT. Attention deficit hyperactivity disorder Translational Neuroscience: Applications in Psychiatry, Neurology, and Neurodevelopmental Disorders. 303-320. DOI: 10.1017/CBO9780511980053.018  1
2012 Berridge CW, Devilbiss DM. Psychostimulants as cognitive enhancers: The prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder | Psicoestimulantes y potenciadores cognitivos: corteza prefrontal, catecolaminas y trastorno por déficit de atención/hiperactividad Psiquiatria Biologica. 19: 84-94. DOI: 10.1016/j.psiq.2012.07.001  1
2011 Agster KL, Clark BD, Gao WJ, Shumsky JS, Wang HX, Berridge CW, Waterhouse BD. Experimental strategies for investigating psychostimulant drug actions and prefrontal cortical function in ADHD and related attention disorders. Anatomical Record (Hoboken, N.J. : 2007). 294: 1698-712. PMID 21901844 DOI: 10.1002/ar.21403  1
2011 Berridge CW, Devilbiss DM. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder. Biological Psychiatry. 69: e101-11. PMID 20875636 DOI: 10.1016/j.biopsych.2010.06.023  1
2010 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Research. 1314: 91-102. PMID 19748490 DOI: 10.1016/j.brainres.2009.09.019  1
2009 Stalnaker TA, España RA, Berridge CW. Coping behavior causes asymmetric changes in neuronal activation in the prefrontal cortex and amygdala. Synapse (New York, N.Y.). 63: 82-5. PMID 18932226 DOI: 10.1002/syn.20583  1
2009 Berridge CW. The locus coeruleus-noradrenergic system and stress: Implications for post-traumatic stress disorder Post-Traumatic Stress Disorder: Basic Science and Clinical Practice. 213-230. DOI: 10.1007/978-1-60327-329-9_10  1
2009 Arnsten AFT, Berridge CW, McCracken JT. The neurobiological basis of attention-deficit/hyperactivity disorder Primary Psychiatry. 16: 47-54.  1
2008 Vittoz NM, Schmeichel B, Berridge CW. Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. The European Journal of Neuroscience. 28: 1629-40. PMID 18973582 DOI: 10.1111/j.1460-9568.2008.06453.x  1
2008 Devilbiss DM, Berridge CW. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biological Psychiatry. 64: 626-35. PMID 18585681 DOI: 10.1016/j.biopsych.2008.04.037  1
2008 Berridge CW. Noradrenergic modulation of arousal. Brain Research Reviews. 58: 1-17. PMID 18199483 DOI: 10.1016/j.brainresrev.2007.10.013  1
2006 Conti LH, Berridge CW, Tayler JE. Both corticotropin-releasing factor and apomorphine reduce prepulse inhibition following repeated central infusion of corticotropin-releasing factor. Pharmacology, Biochemistry, and Behavior. 85: 261-72. PMID 16996121 DOI: 10.1016/j.pbb.2006.08.009  1
2006 Devilbiss DM, Berridge CW. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. The Journal of Pharmacology and Experimental Therapeutics. 319: 1327-35. PMID 16980569 DOI: 10.1124/jpet.106.110015  1
2006 Berridge CW. Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2332-40. PMID 16855535 DOI: 10.1038/sj.npp.1301159  1
2006 Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biological Psychiatry. 60: 1111-20. PMID 16806100 DOI: 10.1016/j.biopsych.2006.04.022  1
2006 España RA, Berridge CW. Organization of noradrenergic efferents to arousal-related basal forebrain structures. The Journal of Comparative Neurology. 496: 668-83. PMID 16615125 DOI: 10.1002/cne.20946  1
2006 Mill J, Caspi A, Williams BS, Craig I, Taylor A, Polo-Tomas M, Berridge CW, Poulton R, Moffitt TE. Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. Archives of General Psychiatry. 63: 462-9. PMID 16585476 DOI: 10.1001/archpsyc.63.4.462  1
2006 Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 384-95. PMID 15988471 DOI: 10.1038/sj.npp.1300807  1
2005 Berridge CW, Stellick RL, Schmeichel BE. Wake-promoting actions of medial basal forebrain beta2 receptor stimulation. Behavioral Neuroscience. 119: 743-51. PMID 15998195 DOI: 10.1037/0735-7044.119.3.743  1
2005 Berridge CW, España RA. Hypocretins: waking, arousal, or action? Neuron. 46: 696-8. PMID 15924855 DOI: 10.1016/j.neuron.2005.05.016  1
2005 Dvorak CA, Apodaca R, Barbier AJ, Berridge CW, Wilson SJ, Boggs JD, Xiao W, Lovenberg TW, Carruthers NI. 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists. Journal of Medicinal Chemistry. 48: 2229-38. PMID 15771465 DOI: 10.1021/jm049212n  1
2005 España RA, Reis KM, Valentino RJ, Berridge CW. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. The Journal of Comparative Neurology. 481: 160-78. PMID 15562511 DOI: 10.1002/cne.20369  1
2005 Berridge CW. Chapter 4.3 The locus coeruleus-noradrenergic system and stress: modulation of arousal state and state-dependent behavioral processes Techniques in the Behavioral and Neural Sciences. 15: 437-464. DOI: 10.1016/S0921-0709(05)80025-2  1
2005 Berridge CW, España RA. Hypocretin/orexin in stress and arousal Hypocretins: Integrators of Physiological Functions. 353-367. DOI: 10.1007/0-387-25446-3_24  1
2004 España RA, Berridge CW, Gammie SC. Diurnal levels of Fos immunoreactivity are elevated within hypocretin neurons in lactating mice. Peptides. 25: 1927-34. PMID 15501524 DOI: 10.1016/j.peptides.2004.06.006  1
2004 Barbier AJ, Berridge C, Dugovic C, Laposky AD, Wilson SJ, Boggs J, Aluisio L, Lord B, Mazur C, Pudiak CM, Langlois X, Xiao W, Apodaca R, Carruthers NI, Lovenberg TW. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. British Journal of Pharmacology. 143: 649-61. PMID 15466448 DOI: 10.1038/sj.bjp.0705964  1
2003 España RA, Valentino RJ, Berridge CW. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience. 121: 201-17. PMID 12946712 DOI: 10.1016/S0306-4522(03)00334-8  1
2003 Isaac SO, Berridge CW. Wake-promoting actions of dopamine D1 and D2 receptor stimulation. The Journal of Pharmacology and Experimental Therapeutics. 307: 386-94. PMID 12944496 DOI: 10.1124/jpet.103.053918  1
2003 Stalnaker TA, Berridge CW. AMPA receptor stimulation within the central nucleus of the amygdala elicits a differential activation of central dopaminergic systems. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1923-34. PMID 12915861 DOI: 10.1038/sj.npp.1300268  1
2003 Baldo BA, Daniel RA, Berridge CW, Kelley AE. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. The Journal of Comparative Neurology. 464: 220-37. PMID 12898614 DOI: 10.1002/cne.10783  1
2003 Berridge CW, Isaac SO, España RA. Additive wake-promoting actions of medial basal forebrain noradrenergic alpha1- and beta-receptor stimulation. Behavioral Neuroscience. 117: 350-9. PMID 12708531 DOI: 10.1037/0735-7044.117.2.350  1
2003 Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Research. Brain Research Reviews. 42: 33-84. PMID 12668290 DOI: 10.1016/S0165-0173(03)00143-7  1
2002 Berridge CW, Stalnaker TA. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse (New York, N.Y.). 46: 140-9. PMID 12325041 DOI: 10.1002/syn.10131  1
2002 Lin SH, Arai AC, España RA, Berridge CW, Leslie FM, Huguenard JR, Vergnes M, Civelli O. Prolactin-releasing peptide (PrRP) promotes awakening and suppresses absence seizures. Neuroscience. 114: 229-38. PMID 12207968 DOI: 10.1016/S0306-4522(02)00248-8  1
2002 España RA, Plahn S, Berridge CW. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Research. 943: 224-36. PMID 12101045 DOI: 10.1016/S0006-8993(02)02653-7  1
2001 España RA, Baldo BA, Kelley AE, Berridge CW. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience. 106: 699-715. PMID 11682157 DOI: 10.1016/S0306-4522(01)00319-0  1
2001 Berridge CW, O'Neill J. Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominata. Behavioral Neuroscience. 115: 165-74. PMID 11256440  1
2000 Berridge CW, España RA. Synergistic sedative effects of noradrenergic alpha(1)- and beta-receptor blockade on forebrain electroencephalographic and behavioral indices. Neuroscience. 99: 495-505. PMID 11029541 DOI: 10.1016/S0306-4522(00)00215-3  1
2000 Berridge CW, Wifler K. Contrasting effects of noradrenergic beta-receptor blockade within the medial septal area on forebrain electroencephalographic and behavioral activity state in anesthetized and unanesthetized rat. Neuroscience. 97: 543-52. PMID 10828536 DOI: 10.1016/S0306-4522(00)00047-6  1
2000 Berridge CW, Morris MF. Amphetamine-induced activation of forebrain EEG is prevented by noradrenergic beta-receptor blockade in the halothane-anesthetized rat. Psychopharmacology. 148: 307-13. PMID 10755744  1
1999 Berridge CW, Abercrombie ED. Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis. Neuroscience. 93: 1263-70. PMID 10501450 DOI: 10.1016/S0306-4522(99)00276-6  1
1999 Berridge CW, O'Neil J, Wifler K. Amphetamine acts within the medial basal forebrain to initiate and maintain alert waking. Neuroscience. 93: 885-96. PMID 10473254 DOI: 10.1016/S0306-4522(99)00271-7  1
1999 Weninger SC, Dunn AJ, Muglia LJ, Dikkes P, Miczek KA, Swiergiel AH, Berridge CW, Majzoub JA. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proceedings of the National Academy of Sciences of the United States of America. 96: 8283-8. PMID 10393986 DOI: 10.1073/pnas.96.14.8283  1
1999 Berridge CW, Mitton E, Clark W, Roth RH. Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse (New York, N.Y.). 32: 187-97. PMID 10340629 DOI: 10.1002/(SICI)1098-2396(19990601)32:3<187::AID-SYN5>3.0.CO;2-9  1
1998 Berridge CW. Modulation of forebrain electroencephalographic activity and behavioral state by the locus ceruleus-noradrenergic system: involvement of the medial septal area. Advances in Pharmacology (San Diego, Calif.). 42: 744-8. PMID 9328006 DOI: 10.1016/S1054-3589(08)60855-8  1
1997 Berridge CW, Stratford TL, Foote SL, Kelley AE. Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse (New York, N.Y.). 27: 230-41. PMID 9329158 DOI: 10.1002/(SICI)1098-2396(199711)27:3<230::AID-SYN8>3.0.CO;2-E  1
1996 Berridge CW, Bolen SJ, Manley MS, Foote SL. Modulation of forebrain electroencephalographic activity in halothane-anesthetized rat via actions of noradrenergic beta-receptors within the medial septal region. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 7010-20. PMID 8824337  1
1996 Berridge CW, Foote SL. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 6999-7009. PMID 8824336  1
1994 Davis M, Hitchcock JM, Bowers MB, Berridge CW, Melia KR, Roth RH. Stress-induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala. Brain Research. 664: 207-10. PMID 7895029 DOI: 10.1016/0006-8993(94)91972-0  1
1994 Berridge CW, Foote SL. Locus coeruleus-induced modulation of forebrain electroencephalographic (EEG) state in halothane-anesthetized rat. Brain Research Bulletin. 35: 597-605. PMID 7859117 DOI: 10.1016/0361-9230(94)90174-0  1
1993 Moghaddam B, Berridge CW, Goldman-Rakic PS, Bunney BS, Roth RH. In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse (New York, N.Y.). 13: 215-22. PMID 8497807 DOI: 10.1002/syn.890130304  1
1993 Berridge CW, Arnsten AF, Foote SL. Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioural studies in animal models. Psychological Medicine. 23: 557-64. PMID 8234565  1
1993 Page ME, Berridge CW, Foote SL, Valentino RJ. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neuroscience Letters. 164: 81-4. PMID 8152620 DOI: 10.1016/0304-3940(93)90862-F  1
1993 Berridge CW, Page ME, Valentino RJ, Foote SL. Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience. 55: 381-93. PMID 8104319 DOI: 10.1016/0306-4522(93)90507-C  1
1991 Foote SL, Berridge CW, Adams LM, Pineda JA. Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Progress in Brain Research. 88: 521-32. PMID 1813932  1
1991 Bradberry CW, Gruen RJ, Berridge CW, Roth RH. Individual differences in behavioral measures: correlations with nucleus accumbens dopamine measured by microdialysis. Pharmacology, Biochemistry, and Behavior. 39: 877-82. PMID 1763106 DOI: 10.1016/0091-3057(91)90047-6  1
1991 Berridge CW, Foote SL. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 3135-45. PMID 1682425  1
1990 Spadaro F, Berridge CW, Baldwin HA, Dunn AJ. Corticotropin-releasing factor acts via a third ventricle site to reduce exploratory behavior in rats. Pharmacology, Biochemistry, and Behavior. 36: 305-9. PMID 2356205 DOI: 10.1016/0091-3057(90)90408-A  1
1990 Berridge CW, Dunn AJ. DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behavior 3 and 14 days after treatment. Psychopharmacology. 100: 504-8. PMID 2320711 DOI: 10.1007/BF02244003  1
1990 Dunn AJ, Berridge CW. Is corticotropin-releasing factor a mediator of stress responses? Annals of the New York Academy of Sciences. 579: 183-91. PMID 2186685 DOI: 10.1111/j.1749-6632.1990.tb48360.x  1
1990 Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Research. Brain Research Reviews. 15: 71-100. PMID 1980834 DOI: 10.1016/0165-0173(90)90012-D  1
1989 Berridge CW, Dunn AJ. Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 3513-21. PMID 2795137  1
1989 Berridge CW, Dunn AJ. CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice. Pharmacology, Biochemistry, and Behavior. 34: 517-9. PMID 2623010 DOI: 10.1016/0091-3057(89)90551-0  1
1988 Dunn AJ, Berridge CW, Lai YI, Yachabach TL, File SE. Excessive grooming behavior in rats and mice induced by corticotropin-releasing factor Annals of the New York Academy of Sciences. 525: 391-393.  1
1987 Dunn AJ, Berridge CW, Lai YI, Yachabach TL. CRF-induced excessive grooming behavior in rats and mice. Peptides. 8: 841-4. PMID 3501576 DOI: 10.1016/0196-9781(87)90069-6  1
1987 Berridge CW, Dunn AJ. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice. Hormones and Behavior. 21: 393-401. PMID 3499373 DOI: 10.1016/0018-506X(87)90023-7  1
1987 Dunn AJ, Berridge CW. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacology, Biochemistry, and Behavior. 27: 685-91. PMID 2443934 DOI: 10.1016/0091-3057(87)90195-X  1
1987 Berridge CW, Dunn AJ. α2-Noradrenergic agonists and antagonists alter exploratory behavior in mice Neuroscience Research Communications. 1: 97-103.  1
1986 Berridge CW, Dunn AJ. Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice. Regulatory Peptides. 16: 83-93. PMID 3492730 DOI: 10.1016/0167-0115(86)90196-5  1
1986 Dunn AJ, Elfvin KL, Berridge CW. Changes in plasma corticosterone and cerebral biogenic amines and their catabolites during training and testing of mice in passive avoidance behavior. Behavioral and Neural Biology. 46: 410-23. PMID 2434072 DOI: 10.1016/S0163-1047(86)90422-X  1
1985 Arnsten AF, Berridge C, Segal DS. Stress produces opioid-like effects on investigatory behavior. Pharmacology, Biochemistry, and Behavior. 22: 803-9. PMID 4011639 DOI: 10.1016/0091-3057(85)90531-3  1
Show low-probability matches.